Drug
Tenapanor Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Insurance Issue | 184 | 74.6 | 78.7 | signal |
| 2 | Therapy Interrupted | 292 | 25.3 | 27.5 | signal |
| 3 | Inability To Afford Medication | 35 | 21.2 | 21.4 | signal |
| 4 | Prescribed Underdose | 68 | 20.3 | 20.7 | signal |
| 5 | Product Use Issue | 430 | 13.7 | 15.5 | signal |
| 6 | Flatulence | 130 | 13.7 | 14.2 | signal |
| 7 | Abdominal Distension | 234 | 13.4 | 14.3 | signal |
| 8 | Inappropriate Schedule Of Product Administration | 391 | 13.2 | 14.7 | signal |
| 9 | Diarrhoea | 1,239 | 11.5 | 17.2 | signal |
| 10 | Intentional Dose Omission | 50 | 10.9 | 11.0 | signal |
| 11 | Underdose | 123 | 10.0 | 10.4 | signal |
| 12 | Product Dose Omission In Error | 38 | 8.4 | 8.5 | signal |
| 13 | Frequent Bowel Movements | 35 | 7.7 | 7.8 | signal |
| 14 | Haemorrhoids | 24 | 7.3 | 7.4 | signal |
| 15 | Impaired Gastric Emptying | 15 | 7.0 | 7.0 | signal |
| 16 | Unevaluable Event | 83 | 6.5 | 6.7 | signal |
| 17 | Drug Effect Less Than Expected | 15 | 6.3 | 6.4 | signal |
| 18 | Product Use In Unapproved Indication | 250 | 6.1 | 6.5 | signal |
| 19 | Illness | 87 | 5.2 | 5.3 | signal |
| 20 | Brain Fog | 12 | 4.9 | 4.9 | signal |
| 21 | Gastrointestinal Pain | 9 | 4.9 | 4.9 | signal |
| 22 | Cholecystectomy | 9 | 4.7 | 4.7 | signal |
| 23 | Therapeutic Product Effect Decreased | 35 | 4.7 | 4.7 | signal |
| 24 | Product Prescribing Issue | 16 | 4.7 | 4.7 | signal |
| 25 | Abdominal Pain Upper | 159 | 4.6 | 4.8 | signal |
| 26 | Blood Sodium Decreased | 14 | 4.4 | 4.4 | signal |
| 27 | Therapy Change | 7 | 4.3 | 4.3 | signal |
| 28 | Spinal Operation | 8 | 3.9 | 3.9 | signal |
| 29 | Feeding Disorder | 13 | 3.9 | 3.9 | signal |
| 30 | Peritonitis | 13 | 3.7 | 3.7 | signal |
| 31 | Therapy Cessation | 32 | 3.7 | 3.8 | signal |
| 32 | Adverse Drug Reaction | 55 | 3.7 | 3.7 | signal |
| 33 | Irritable Bowel Syndrome | 13 | 3.6 | 3.6 | signal |
| 34 | Faeces Discoloured | 13 | 3.6 | 3.6 | signal |
| 35 | Abdominal Pain | 134 | 3.4 | 3.5 | signal |
| 36 | Cerebral Infarction | 14 | 3.4 | 3.4 | signal |
| 37 | Dehydration | 76 | 3.4 | 3.4 | signal |
| 38 | Abdominal Pain Lower | 14 | 3.3 | 3.3 | signal |
| 39 | Product Availability Issue | 12 | 3.2 | 3.2 | signal |
| 40 | Hospitalisation | 81 | 3.2 | 3.2 | signal |
| 41 | Abdominal Discomfort | 87 | 3.1 | 3.2 | signal |
| 42 | Rectal Haemorrhage | 21 | 2.9 | 2.9 | signal |
| 43 | Surgery | 28 | 2.9 | 2.9 | signal |
| 44 | Accidental Underdose | 7 | 2.9 | 2.9 | signal |
| 45 | Wrong Technique In Product Usage Process | 93 | 2.7 | 2.8 | signal |
| 46 | Treatment Noncompliance | 25 | 2.7 | 2.8 | signal |
| 47 | Intestinal Obstruction | 17 | 2.7 | 2.7 | signal |
| 48 | Melaena | 10 | 2.7 | 2.7 | signal |
| 49 | Thirst | 8 | 2.7 | 2.7 | signal |
| 50 | Circumstance Or Information Capable Of Leading To Medication Error | 15 | 2.7 | 2.7 | signal |
| 51 | Diverticulitis | 12 | 2.6 | 2.6 | signal |
| 52 | Eructation | 7 | 2.2 | 2.2 | no signal |
| 53 | Inflammatory Bowel Disease | 3 | 1.8 | 1.8 | no signal |
| 54 | Complication Associated With Device | 4 | 1.8 | 1.8 | no signal |
| 55 | Drug Effective For Unapproved Indication | 8 | 1.6 | 1.6 | no signal |
| 56 | Product Dispensing Error | 5 | 1.4 | 1.4 | no signal |
| 57 | Dysmenorrhoea | 3 | 1.4 | 1.4 | no signal |
| 58 | Exposure Via Skin Contact | 4 | 1.1 | 1.1 | no signal |
| 59 | No Adverse Event | 31 | 1.0 | 1.0 | no signal |
| 60 | Dermatitis Atopic | 5 | 0.6 | 0.6 | no signal |
| 61 | Device Expulsion | 3 | 0.3 | 0.3 | no signal |